unknown
Stage
2024
Founded
3
Investors
About
Alex Therapeutics builds evidence-based companion apps and AI-integrated digital therapies (SaMD) that help patients manage medications and mental-health challenges, partnering with pharmaceutical companies to deliver indication-specific solutions for cancer, rare disease and other complex conditions.
Explore Alex Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.